1. Home
  2. BBNX vs MAGN Comparison

BBNX vs MAGN Comparison

Compare BBNX & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$19.50

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Logo Magnera Corporation

MAGN

Magnera Corporation

N/A

Current Price

$12.63

Market Cap

435.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
BBNX
MAGN
Founded
2015
1864
Country
United States
United States
Employees
N/A
2980
Industry
Medical/Dental Instruments
Paper
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
493.1M
435.4M
IPO Year
2025
1994

Fundamental Metrics

Financial Performance
Metric
BBNX
MAGN
Price
$19.50
$12.63
Analyst Decision
Strong Buy
Hold
Analyst Count
10
1
Target Price
$23.80
$12.00
AVG Volume (30 Days)
960.2K
451.3K
Earning Date
04-21-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
78.95
7.64
EPS
N/A
N/A
Revenue
$100,251,000.00
$3,204,000,000.00
Revenue This Year
$34.90
$5.37
Revenue Next Year
$34.63
$3.47
P/E Ratio
N/A
N/A
Revenue Growth
53.94
46.50
52 Week Low
$8.80
$7.82
52 Week High
$32.71
$15.52

Technical Indicators

Market Signals
Indicator
BBNX
MAGN
Relative Strength Index (RSI) 59.80 50.91
Support Level $9.34 $11.64
Resistance Level $20.74 $12.96
Average True Range (ATR) 1.05 0.50
MACD -0.00 0.03
Stochastic Oscillator 63.55 72.81

Price Performance

Historical Comparison
BBNX
MAGN

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

About MAGN Magnera Corporation

Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.

Share on Social Networks: